PDF herunterladen
CC BY-NC-ND 4.0 · World J Nucl Med 2021; 20(03): 327-328
DOI: 10.4103/wjnm.wjnm_129_20
Letter to Editor

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer

Emmanuel Nii Boye Hammond
1   National Centre for Radiotherapy Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Ghana
2   Ghana Atomic Energy Commission, Ghana
,
Dennis Odai Amoako
1   National Centre for Radiotherapy Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Ghana
,
Dennis Odai Laryea
4   Ghana Health Service Headquarters, Accra, Ghana
,
George Amoah
1   National Centre for Radiotherapy Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Ghana
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Financial support and sponsorship

Nil.




Publikationsverlauf

Eingereicht: 24. September 2020

Angenommen: 28. Oktober 2020

Artikel online veröffentlicht:
24. März 2022

© 2021. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Manohar P, Rather T, Khan S. Determination of the optimal cut-off value of serum prostate-specific antigen in the prediction of skeletal metastases on technetium-99m whole-body bone scan by receiver operating characteristic curve analysis. World J Nucl Med 2020;19:255-9.
  • 2 Adedapo KS, Onimode YA, Ejeh JE, Adepoju AO. Avoidable challenges of a nuclear medicine facility in a developing nation. Indian J Nucl Med 2013;28:195-9.
  • 3 Amoako YA, Hammond ENB, Assasie-Gyimah A, Laryea DO, Ankrah A, Amoah G. Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer. World J Nucl Med 2019;18:143-8.
  • 4 Ritenour CW, Abbott JT, Goodman M, Alazraki N, Marshall FF, Issa MM. The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients. Sci World J 2009;9:1040-5.
  • 5 Kamaleshwaran KK, Mittal BR, Harisankar CN, Bhattacharya A, Singh SK, Mandal AK. Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy. Indian J Nucl Med 2012;27:81-4.